The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Adolescent

Back to Details
This is a "connection" page, showing publications Kenneth S. Cohen has written about Adolescent.
Kenneth S. Cohen
Connection Strength
0.578
Adolescent
  1. Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol. 2014 Dec; 15(4):581-94.
    View in: PubMed
    Score: 0.050
  2. A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Jun; 15(6):783-7.
    View in: PubMed
    Score: 0.044
  3. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
    View in: PubMed
    Score: 0.038
  4. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol. 2011 Apr; 13(4):410-6.
    View in: PubMed
    Score: 0.038
  5. Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected? J Neurooncol. 2002 Apr; 57(2):123-6.
    View in: PubMed
    Score: 0.021
  6. Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg. 2001 May; 34(5):229-34.
    View in: PubMed
    Score: 0.019
  7. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
    View in: PubMed
    Score: 0.019
  8. Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg. 2000 Jan; 32(1):24-9.
    View in: PubMed
    Score: 0.018
  9. Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clin Cancer Res. 2019 12 15; 25(24):7303-7311.
    View in: PubMed
    Score: 0.018
  10. A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors. Clin Cancer Res. 2019 12 15; 25(24):7294-7302.
    View in: PubMed
    Score: 0.017
  11. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2018 10 09; 20(11):1547-1555.
    View in: PubMed
    Score: 0.016
  12. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
    View in: PubMed
    Score: 0.016
  13. Association of Neuronal Injury in the Genu and Body of Corpus Callosum After Cranial Irradiation in Children With Impaired Cognitive Control: A Prospective Study. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1234-1242.
    View in: PubMed
    Score: 0.016
  14. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
    View in: PubMed
    Score: 0.015
  15. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.015
  16. A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation. Cancer. 2017 Jan 01; 123(1):161-168.
    View in: PubMed
    Score: 0.014
  17. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy. Childs Nerv Syst. 2016 Aug; 32(8):1425-30.
    View in: PubMed
    Score: 0.014
  18. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50.
    View in: PubMed
    Score: 0.014
  19. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol. 2014 Aug; 38(8):1058-70.
    View in: PubMed
    Score: 0.012
  20. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 2014 Nov; 16(11):1554-9.
    View in: PubMed
    Score: 0.012
  21. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol. 2014 Oct; 16(10):1408-16.
    View in: PubMed
    Score: 0.012
  22. Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade? Pediatr Blood Cancer. 2013 Dec; 60(12):2036-41.
    View in: PubMed
    Score: 0.011
  23. Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013 Oct; 49(4):237-42.
    View in: PubMed
    Score: 0.011
  24. Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1307-11.
    View in: PubMed
    Score: 0.011
  25. Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013 Mar; 15(3):360-9.
    View in: PubMed
    Score: 0.011
  26. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol. 2012 Nov; 124(5):627-41.
    View in: PubMed
    Score: 0.011
  27. Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):421-7.
    View in: PubMed
    Score: 0.010
  28. Magnetic resonance imaging features of meningiomas in children and young adults: a retrospective analysis. J Neuroradiol. 2012 Oct; 39(4):218-26.
    View in: PubMed
    Score: 0.010
  29. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug; 99(1):65-71.
    View in: PubMed
    Score: 0.009
  30. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009 Jan 20; 27(3):385-9.
    View in: PubMed
    Score: 0.008
  31. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008 Aug; 51(2):245-50.
    View in: PubMed
    Score: 0.008
  32. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer. 2007 Dec 01; 110(11):2535-41.
    View in: PubMed
    Score: 0.008
  33. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006 Feb; 23(2):99-107.
    View in: PubMed
    Score: 0.007
  34. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004 May; 63(5):441-9.
    View in: PubMed
    Score: 0.006
  35. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3):198-203.
    View in: PubMed
    Score: 0.006
  36. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol. 2002 Jan; 12(1):36-44.
    View in: PubMed
    Score: 0.005
  37. No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
    View in: PubMed
    Score: 0.005
  38. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.